Probiotix Health PLC - Appointment of Aquis Corporate Adviser
Announcement provided by
ProBiotix Health Plc · PBX23/10/2025 07:00
23 October 2025
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Appointment of Aquis Corporate Adviser
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that AlbR Capital Limited has been appointed as Aquis Corporate Adviser to the Company with immediate effect.
For further information, please contact:
|
ProBiotix Health plc |
|
|
|
|
|
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations |
|
|
|
|
|
AlbR Capital Limited
Aquis Corporate Adviser and Broker |
Tel: 020 7469 0930 |
|
|
|
Notes to Editors:
ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a singular approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
